For research use only. Not for therapeutic Use.
TDRL-551 is a novel small-molecule antiviral agent under investigation for its potential to treat viral infections. It is designed to inhibit the replication of specific viruses by targeting critical viral proteins or host factors essential for the viral life cycle. TDRL-551 has shown promise in preclinical studies for its broad-spectrum antiviral activity, particularly against RNA viruses. Research on TDRL-551 focuses on its efficacy, safety, and potential applications in managing emerging viral diseases, including those with limited treatment options.
| Catalog Number | I009730 |
| CAS Number | 1644626-43-6 |
| Synonyms | 5-[3-(2-chloro-7-ethoxyquinolin-3-yl)-5-(4-iodophenyl)-3,4-dihydropyrazol-2-yl]-5-oxopentanoic acid |
| Molecular Formula | C25H23ClIN3O4 |
| Purity | ≥95% |
| InChI | InChI=1S/C25H23ClIN3O4/c1-2-34-18-11-8-16-12-19(25(26)28-20(16)13-18)22-14-21(15-6-9-17(27)10-7-15)29-30(22)23(31)4-3-5-24(32)33/h6-13,22H,2-5,14H2,1H3,(H,32,33) |
| InChIKey | QHNTZIUSUGGSNE-UHFFFAOYSA-N |
| SMILES | CCOC1=CC2=NC(=C(C=C2C=C1)C3CC(=NN3C(=O)CCCC(=O)O)C4=CC=C(C=C4)I)Cl |
